Tag:
Strides Arcolab
Latest Headlines
Latest Headlines
Strides Arcolab picks up injectables plant
Three months after selling its Australia formulations business to Watson Pharmaceuticals, Strides Arcolab is in the hunt for strategic acquisitions.
Watson expands Asian footprint with $392M generics buy
Watson Pharmaceuticals ( $WPI ) expanded its reach in the Asia-Pacific with a deal to buy Strides Arcolab's Australia-based generics business, which is known as Ascent Pharmahealth. The buyout not only
India's Strides flirts with sale of generics unit
Comment or no comment? Strides Arcolab's managing director made headlines earlier this week by suggesting that the company might be open to selling off a business unit that makes generic pills and
Pfizer partner Strides nabs FDA plant approval
India's Strides Arcolab got a second key facility approval from the FDA. Its oncology unit won the agency's nod for its new production plant in Bangalore, clearing the way for its partnership with
Pfizer broadens Strides supply deal to new markets, meds
Pfizer ( NYSE: PFE ) and Strides Arcolab have broadened their supply arrangement in yet another move by the pharma behemoth toward generic meds. Under the new agreement, Strides will license and supply
Pfizer boosts generics unit with Strides deal
One small step for Pfizer, another leap farther into generics for Big Pharma . The drugmaker has agreed to source 40 generic treatments--including a bundle of cancer meds--from the Indian firm Strides
